Search NCS Home
SEARCH
Search
Advanced Search
Currents
Provided by
Neurocritical Care Society
  • About Currents
  • Leading Insights
  • Literature Watch
  • NCS News
  • Stories of Hope
When the Algorithm (And Education) Aren’t Enough: Clinical Judgment in the Neuro ICU When the Algorithm (And Education) Aren’t Enough: Clinical Judgment in the Neuro ICU
Leading Insights
When the Algorithm (And Education) Aren’t Enough: Clinical Judgment in the Neuro ICU
Written By: Jordan Yakoby, EdD, DNP, ACNP-BC, CCRN, CNE, FNYAM, FCCM, FNCS
In my view, modern healthcare is plagued by two critical issues: the excessive reverence of protocols at the expense of sound clinical judgment and a looming educational crisis. Algorithms, protocols, and checklists guide many aspects of care, especially in the care of patients suffering from...
Neurocritical care society

Neurocritical Care Insights And
Perspectives From Around the World

Join Our Mailing List
A Shot in the Dark: Are Intrathecal Therapies Effective for NMDA Receptor Encephalitis?
Leading Insights, Pharmacy
A Shot in the Dark: Are Intrathecal Therapies Effective for NMDA Receptor Encephalitis?
Written By: Nicolas Chiriboga, MD; Jose Irazuzta, MD

Autoimmune encephalitis (AIE) is a very frequently diagnosed type of encephalitis in middle-to-high-income countries.

Virtual Reality for Neurorehabilitation: Mechanisms, Modalities, and Clinical Applications
Leading Insights
Virtual Reality for Neurorehabilitation: Mechanisms, Modalities, and Clinical Applications
Written By: Shane Musick, MD; Nilufer Yalcin, MD

Virtual reality (VR) has transitioned from a speculative technology to a clinically validated tool in neurorehabilitation, offering unique opportunities to address the complex needs of neurocritical care patients.

View More

Apixaban to Prevent Covert Infarcts after Cryptogenic Stroke in Patients with Atrial Cardiopathy: A Secondary Analysis of the ARCADIA Randomized Clinical Trial
NCS News
Apixaban to Prevent Covert Infarcts after Cryptogenic Stroke in Patients with Atrial Cardiopathy: A Secondary Analysis of the ARCADIA Randomized Clinical Trial
Written By: William Spears, MD

Background: The recently published ARCADIA trial, which enrolled patients with ESUS and signs of atrial cardiopathy, failed to show that treatment with anticoagulation prevented recurrent ischemic stroke.

Contact Us

Curing Coma®

Currents

Neurocritical Care Foundation

Neurocritical Care

Neurocritical Care Society
330 N Wabash Ave. Suite 2000, Chicago, IL 60611
PHONE  1.312.321.5159  |  FAX  1.312.673.6759
info@neurocriticalcare.org
Login
Privacy Statement  |  Terms & Conditions  |  © Neurocritical Care Society
Search